252 related articles for article (PubMed ID: 23745563)
1. Canonical and non-canonical barriers facing antimiR cancer therapeutics.
Cheng CJ; Saltzman WM; Slack FJ
Curr Med Chem; 2013; 20(29):3582-93. PubMed ID: 23745563
[TBL] [Abstract][Full Text] [Related]
2. Trials and Tribulations of MicroRNA Therapeutics.
Seyhan AA
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338746
[TBL] [Abstract][Full Text] [Related]
3. Comparison of interaction between antimiR and microRNA versus HDO-antimiR and microRNA by molecular dynamics simulation.
Nishina K; Yoshioka K; Yokota T; Hara RI
Nucleosides Nucleotides Nucleic Acids; 2024 Jan; ():1-16. PubMed ID: 38205778
[TBL] [Abstract][Full Text] [Related]
4. Correction to Chemically Modified Platforms for Better RNA Therapeutics.
Shi Y; Zhen X; Zhang Y; Li Y; Koo S; Saiding Q; Kong N; Liu G; Chen W; Tao W
Chem Rev; 2024 May; 124(10):6690-6692. PubMed ID: 38688000
[No Abstract] [Full Text] [Related]
5. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.
Cheng CJ; Bahal R; Babar IA; Pincus Z; Barrera F; Liu C; Svoronos A; Braddock DT; Glazer PM; Engelman DM; Saltzman WM; Slack FJ
Nature; 2015 Feb; 518(7537):107-10. PubMed ID: 25409146
[TBL] [Abstract][Full Text] [Related]
6. Development of microRNA therapeutics is coming of age.
van Rooij E; Kauppinen S
EMBO Mol Med; 2014 Jul; 6(7):851-64. PubMed ID: 24935956
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix.
Hunt JF; Rath P; Rothschild KJ; Engelman DM
Biochemistry; 1997 Dec; 36(49):15177-92. PubMed ID: 9398245
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of microRNAs: current status and future challenges.
Li Z; Rana TM
Nat Rev Drug Discov; 2014 Aug; 13(8):622-38. PubMed ID: 25011539
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.
Prakash TP; Graham MJ; Yu J; Carty R; Low A; Chappell A; Schmidt K; Zhao C; Aghajan M; Murray HF; Riney S; Booten SL; Murray SF; Gaus H; Crosby J; Lima WF; Guo S; Monia BP; Swayze EE; Seth PP
Nucleic Acids Res; 2014 Jul; 42(13):8796-807. PubMed ID: 24992960
[TBL] [Abstract][Full Text] [Related]
10. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.
Vaupel P; Kallinowski F; Okunieff P
Cancer Res; 1989 Dec; 49(23):6449-65. PubMed ID: 2684393
[TBL] [Abstract][Full Text] [Related]
11. Targeting non-coding RNA family members with artificial endonuclease XNAzymes.
Donde MJ; Rochussen AM; Kapoor S; Taylor AI
Commun Biol; 2022 Sep; 5(1):1010. PubMed ID: 36153384
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
Dhuri K; Gaddam RR; Vikram A; Slack FJ; Bahal R
Cancer Res; 2021 Nov; 81(22):5613-5624. PubMed ID: 34548334
[TBL] [Abstract][Full Text] [Related]
13. MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy.
Aránega AE; Lozano-Velasco E; Rodriguez-Outeiriño L; Ramírez de Acuña F; Franco D; Hernández-Torres F
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921834
[No Abstract] [Full Text] [Related]
14. Epigenetic Effects Mediated by Antiepileptic Drugs and their Potential Application.
Kong FC; Ma CL; Zhong MK
Curr Neuropharmacol; 2020; 18(2):153-166. PubMed ID: 31660836
[TBL] [Abstract][Full Text] [Related]
15. Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis.
Smit KN; Chang J; Derks K; Vaarwater J; Brands T; Verdijk RM; Wiemer EAC; Mensink HW; Pothof J; de Klein A; Kilic E
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212861
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles show promise for cancer theranostics.
Segal M; Slack FJ
Ann Transl Med; 2019 Apr; 7(7):158. PubMed ID: 31157278
[No Abstract] [Full Text] [Related]
17. Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).
Dhanasekaran R; Gabay-Ryan M; Baylot V; Lai I; Mosley A; Huang X; Zabludoff S; Li J; Kaimal V; Karmali P; Felsher DW
Oncotarget; 2018 Jan; 9(5):5517-5528. PubMed ID: 29464015
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.
Quijano E; Bahal R; Ricciardi A; Saltzman WM; Glazer PM
Yale J Biol Med; 2017 Dec; 90(4):583-598. PubMed ID: 29259523
[TBL] [Abstract][Full Text] [Related]
19. miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
Tseng JH; Bisogna M; Hoang LN; Olvera N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Levine DA; Jelinic P
Sci Rep; 2017 Jun; 7(1):3614. PubMed ID: 28620240
[TBL] [Abstract][Full Text] [Related]
20.
Shilo V; Mor-Yosef Levi I; Abel R; Mihailović A; Wasserman G; Naveh-Many T; Ben-Dov IZ
J Am Soc Nephrol; 2017 Aug; 28(8):2353-2363. PubMed ID: 28298326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
